Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Mental Health Technologies Co.,Ltd. (9218.T)
Tokyo, JP
Operating in Japan, Mental Health Technologies Co.,Ltd. offers a diverse portfolio of services, encompassing mental wellness solutions, career development assistance for medical professionals, and digital advertising. The company additionally manages a cloud-based platform for industrial healthcare practitioners. Established in 2011, its corporate headquarters are located in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.43% | -7.78% | -10.94% | -9.02% | -18.36% | -16.85% | -6.76% | -38.26% | -24.64% | -24.64% | -24.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%+25.3% ★ Q1'26: +20.3% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+925.0% ★ Q1'26: -22.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+7.0% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+7.5% Q1'26: +6.2% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%+10.7% ★ Q1'26: +7.5% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+3.9% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×3.96× Q1'26: 5.04× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
2.29B
est: 2.32B (-1.4%)
|
2.61B
est: 2.85B (-8.5%)
|
5.13B
est: 5.15B (-0.3%)
|
6.44B
est: 6.45B (-0.2%)
|
8.40B
8.40B – 8.40B
+30.2% YoY
|
10.20B
10.20B – 10.20B
+21.4% YoY
|
12.00B
12.00B – 12.00B
+17.6% YoY
|
| EBITDA |
396.89M
est: 199.57M (+98.9%)
|
534.92M
est: 245.16M (+118.2%)
|
257.59M
est: 663.03M (-61.2%)
|
661.94M
est: 830.39M (-20.3%)
|
1.08B
1.08B – 1.08B
+30.2% YoY
|
1.31B
1.31B – 1.31B
+21.4% YoY
|
1.54B
1.54B – 1.54B
+17.6% YoY
|
| EBIT |
369.92M
est: 154.82M (+138.9%)
|
501.09M
est: 190.18M (+163.5%)
|
109.75M
est: 561.76M (-80.5%)
|
479.69M
est: 703.56M (-31.8%)
|
916.26M
916.26M – 916.26M
+30.2% YoY
|
1.11B
1.11B – 1.11B
+21.4% YoY
|
1.31B
1.31B – 1.31B
+17.6% YoY
|
| Net Income |
265.12M
est: 320.85M (-17.4%)
|
441.37M
est: 380.95M (+15.9%)
|
-29.78M
est: -10.58M (-181.4%)
|
254.90M
est: 366.14M (-30.4%)
|
435.98M
435.98M – 435.98M
+19.1% YoY
|
688.89M
688.89M – 688.89M
+58.0% YoY
|
891.01M
891.01M – 891.01M
+29.3% YoY
|
| SGA |
1.03B
est: 1.01B (+2.5%)
|
914.20M
est: 1.24B (-26.2%)
|
1.65B
est: 1.82B (-9.0%)
|
1.43B
est: 2.28B (-37.0%)
|
2.96B
2.96B – 2.96B
+30.2% YoY
|
3.60B
3.60B – 3.60B
+21.4% YoY
|
4.23B
4.23B – 4.23B
+17.6% YoY
|
| EPS |
26.96
est: 31.50 (-14.4%)
|
44.29
est: 37.40 (+18.4%)
|
-2.92
est: -1.00 (-192.0%)
|
24.56
est: 34.60 (-29.0%)
|
41.20
41.20 – 41.20
+19.1% YoY
|
65.10
65.10 – 65.10
+58.0% YoY
|
84.20
84.20 – 84.20
+29.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 5/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-01 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shinnosuke Tone | President & Representative Director | — | male |
| Takahisa Watanabe | General Manager of Corporate Headquarters | — | — |
| Yusuke Matsumoto | GM of Digital Marketing Business Division & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 9218.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
